Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3651_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
51 Мб
Скачать
276
https://t.me/medicina_free
R. Le Bouar et al.
encountered. In the case of inferior myocardial infarction, the orientation of the VT isthmus is parallel to the mitral valve, and one loop is usu­ally a peri-mitral loop [24]. Such is probably the case of the above-presented patient (see Fig.17.9). We use the word “probably” because the activation map is incomplete and only the exit zone was precisely identied with this technique. Given the fact that not enough points were acquired with the pacing during sinus rhythm technique and that the VT was not induced during the ablation procedure to allow the creation of a complete activation map, the VT mechanism in this particular patient (dual-loop macro-reentry or single-loop macro-reentry) could not be fully described. However, given the fact that the main components of the VT circuit were identied (entrance zone, VT isthmus, and exit zone), cath­eter ablation was successfully performed.
Another important observation is related to the fact that our patient presented both sustained monomorphic VT (as evidenced in Fig.17.2) and frequent monomorphic PVCs, with the morphol­ogy being identical to the VT morphology. Figure 17.8 shows the activation map of the LV targeting the frequent PVCs and localizing their origin at the level of the inferior and basal LV.One would maybe be tempted to ablate the origin of this PVC and, given the perfect match between the PVC morphology and the VT morphology, con­sider the ablation procedure terminated. However, given the macro-reentry mechanism of the VT, we would like to draw attention to the fact that this represents only the exit site of the VT and that ablation of this region only, risks not to be efcient in the treatment of VT. An efcient ablation of macro-reentry VT requires transaction of the VT isthmus by the ablation lesions, not of the exit zone, since ablating the exit zone only can allow for a different exit zone to develop, given the intact nature of the VT isthmus. This is the reason for which ablation was performed in this case both in the exit zone of the VT (for PVC elimination) and in the VT isthmus zone (for VT elimination).
The techniques used in this case in order to identify the VT and the PVC origin were sub­strate mapping (identication of the zone of myocardial scar, which represented the origin of the PVCs and of the VT, Fig. 17.7), activation
mapping (for the PVC, Fig.17.8), and pacemap­ping during sinus rhythm (for identication of the critical components of the VT, Figs.17.9 and
17.10), as described by de Chillou etal. [1, 2].
This technique is widely presented in the com­mentary section of Case 14. In brief, the tech­nique of pacemapping during sinus rhythm requires comparison between the QRS morphol­ogy resulted from local pacing at a specic site and the morphology of the VT recorded by the 12-lead surface ECG. Using the PASO correla­tion algorithm of the CARTO system, the corre­lation between these two morphologies can be estimated, and this can take values from −100% (in case of complete discordance between the 2) to 100% (perfect match). Several points from areas located in the possible VT origin are paced at twice the diastolic threshold at the VT cycle length, and the percentage of correlation is repre­sented on a CARTO map, with red color corre­sponding to the best match and violet to the poorest match. Orange, yellow, green, and blue colors represent intermediate matches. In the VT exit zone and close to it, there will be good cor­relations between the locally generated QRS morphology and the 12-lead VT morphology. This is due to the fact that the depolarization wavefront travels in the same direction during local pacing as during VT. In the VT entrance zone, there will be a poor correlation between the locally generated QRS morphology and the 12-lead VT morphology. This is due to the fact that the depolarization wavefront travels in oppo­site direction during local pacing and during VT, since during local pacing, the wavefront propa­gates faster from the entrance zone to the sur­rounding healthy myocardial tissue than during myocardial scar, where conduction velocity is signicantly decreased. According to de Chillou etal. [1, 2], regarding VT isthmuses, the best cor­relation percentages are found in the VT exit zones and isthmus exit part (89% ±8% and 84%±7%, respectively), and the poorest correla­tions are found close to the scar border in the outer entrance zones (23% ± 28%), in the entrance zones (39%±34%), and in the entrance part of the isthmus (32% ±26%).
In the above-presented patient, given the fact
that the mapping phase was performed with the
17 C ase 17
https://t.me/medicina_free
277
roving/ablation catheter only and no Pentaray catheter was used, the bipolar voltage map of the LV during sinus rhythm is incomplete (Fig.17.7). However, it was complete enough in order to uncover the low-voltage area which served as substrate both for the frequent monomorphic PVCs and for the VT.
Regarding the approach of the left ventricle used in this case, we chose the retrograde aortic approach. The transseptal approach is the alterna­tive to the retrograde aortic approach, which has its advantages (lower percentage of vascular complications since no arterial puncture is needed) and disadvantages (limitation in catheter manipulation at the level of the IV septum). The two approaches can be combined during the same procedure and often offer better access to differ­ent areas of the left ventricle. The choice between one or the other is very operator dependent. In the above-presented case, the retrograde transaortic approach was enough to map the LV area around the mitral valve.
Learning Points
• Catheter ablation is a viable treatment option for ventricular tachycardia in patients with ischemic heart disease.
• Creation of a pacemap during sinus rhythm is a viable strategy for identify­ing the mechanism and origin of ven­tricular tachycardia.
• An electro-anatomical mapping system is a very useful tool in guiding the abla­tion procedure.
References
1. de Chillou C, Groben L, Magnin-Poull I, Andronache M, MagdiAbbas M, Zhang N, et al. Localizing the critical isthmus of postinfarct ventricular tachycardia: the value of pace-mapping during sinus rhythm. Heart Rhythm. 2014;11(2):175–81.
2. de Chillou C, Sellal JM, Magnin-Poull I.Pace mapping to localize the critical isthmus of ventricular tachycar­dia. Card Electrophysiol Clin. 2017;9(1):71–80.
3. Antunes E, Brugada J, Steurer G, Andries E, Brugada P.The differential diagnosis of a regular tachycardia with a wide QRS complex on the 12-lead ECG: ven-
tricular tachycardia, supraventricular tachycardia with aberrant intraventricular conduction, and supraven­tricular tachycardia with anterograde conduction over an accessory pathway. Pacing Clin Electrophysiol. 1994;17(9):1515–24.
4. Brady WJ, Skiles J. Wide QRS complex tachycar­dia: ECG differential diagnosis. Am J Emerg Med. 1999;17(4):376–81.
5. Miller JM, Das MK, Yadav AV, Bhakta D, Nair G, Alberte C. Value of the 12-lead ECG in wide QRS tachycardia. Cardiol Clin. 2006;24(3):439–51, ix-x.
6. Patil R, Rawat A, Ravikishore AG. Practical guide to ECG diagnosis of wide QRS tachycardia. Indian Heart J. 2011;63(4):312–5.
7. Vereckei A. Current algorithms for the diagnosis of wide QRS complex tachycardias. Curr Cardiol Rev. 2014;10(3):262–76.
8. Vereckei A, Duray G, Szenasi G, Altemose GT, Miller JM.Application of a new algorithm in the differen­tial diagnosis of wide QRS complex tachycardia. Eur Heart J. 2007;28(5):589–600.
9. Vereckei A, Duray G, Szenasi G, Altemose GT, Miller JM. New algorithm using only lead aVR for differ­ential diagnosis of wide QRS complex tachycardia. Heart Rhythm. 2008;5(1):89–98.
10. Steurer G, Gursoy S, Frey B, Simonis F, Andries E, Kuck K, etal. The differential diagnosis on the electro­cardiogram between ventricular tachycardia and pre­excited tachycardia. Clin Cardiol. 1994;17(6):306–8.
11. Wellens HJ, Brugada P. Diagnosis of ventricular tachycardia from the 12-lead electrocardiogram. Cardiol Clin. 1987;5(3):511–25.
12. Ozin B. Differential diagnosis of wide QRS com­plex tachycardias by ECG.Turk Kardiyol Dern Ars. 2012;40(6):552–6.
13. Szelenyi Z, Duray G, Katona G, Frituz G, Szego E, Kovacs E, etal. Comparison of the "real-life" diag­nostic value of two recently published electrocar­diogram methods for the differential diagnosis of wide QRS complex tachycardias. Acad Emerg Med. 2013;20(11):1121–30.
14. Katritsis DG, Brugada J. Differential diagnosis of wide QRS tachycardias. Arrhythmia Electrophysiol Rev. 2020;9(3):155–60.
15. Shlevkov NB, Salami HF, Kiktev VG, Sokolov SF. New ECG criteria for differential diagnosis of wide QRS complex tachycardias with right bundle branch block pattern. Ter Arkh. 2019;91(4):83–9.
16. Colin Lizalde Lde J. Electrocardiogram in the dif­ferential diagnosis of wide-QRS tachycardias. Arch Cardiol Mex. 2004;74(Suppl 1):S44–9.
17. Kaiser E, Darrieux FC, Barbosa SA, Grinberg R, Assis-Carmo A, Sousa JC, et al. Differential diag­nosis of wide QRS tachycardias: comparison of two electrocardiographic algorithms. Europace. 2015;17(9):1422–7.
18. Brugada P, Brugada J, Mont L, Smeets J, Andries EW. A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex. Circulation. 1991;83(5):1649–59.
278
https://t.me/medicina_free
R. Le Bouar et al.
19. Alcaine A, Jauregui B, Soto-Iglesias D, Acosta J, Penela D, Fernandez-Armenta J, et al. Automatic detection of slow conducting channels during sub­strate ablation of scar-related ventricular arrhythmias. J Interv Cardiol. 2020;2020:4386841.
20. Andreu D, Penela D, Acosta J, Fernandez-Armenta J, Perea RJ, Soto-Iglesias D, et al. Cardiac mag­netic resonance-aided scar dechanneling: inuence on acute and long-term outcomes. Heart Rhythm. 2017;14(8):1121–8.
21. Berruezo A, Fernandez-Armenta J, Andreu D, Penela D, Herczku C, Evertz R, et al. Scar dechanneling: new method for scar-related left ventricular tachycar­dia substrate ablation. Circ Arrhythm Electrophysiol. 2015;8(2):326–36.
22. Codreanu A, Odille F, Aliot E, Marie PY, Magnin­Poull I, Andronache M, etal. Electroanatomic char-
acterization of post-infarct scars comparison with 3-dimensional myocardial scar reconstruction based on magnetic resonance imaging. J Am Coll Cardiol. 2008;52(10):839–42.
23. Anderson RD, Ariyarathna N, Lee G, Virk S, Trivic I, Campbell T, etal. Catheter ablation versus medical therapy for treatment of ventricular tachycardia asso­ciated with structural heart disease: systematic review and meta-analysis of randomized controlled trials and comparison with observational studies. Heart Rhythm. 2019;16(10):1484–91.
24. de Chillou C, Lacroix D, Klug D, Magnin-Poull I, Marquie C, Messier M, etal. Isthmus characteristics of reentrant ventricular tachycardia after myocardial infarction. Circulation. 2002;105(6):726–31.
Case 18
https://t.me/medicina_free
RonanLe Bouar, FrédéricHalbwachs, DidierBresson, AubrietiaLawson, MarineKinnel, LaurentDietrich, DavidKenizou, andLaurentJacquemin
18
Case Presentation
A 43-year-old male patient with a history of remote inferior myocardial infarction at the age of 33 years (thrombotic occlusion of the right coronary artery in the proximal segment) treated with PTCA + stent implantation 4h after symp­toms onset; intra-stent restenosis 1 year after, treated with PTCA + stent implantation; isch­emic cardiomyopathy with mild to moderate LV systolic dysfunction (LVEF of 44%); pulmonary
Supplementary Information The online version con­tains supplementary material available at https://doi.org/
10.1007/978- 3- 031- 35579- 0_18.
R. Le Bouar (*) · D. Bresson · A. Lawson M. Kinnel · L. Dietrich · D. Kenizou · L. Jacquemin Cardiology Department, “Emile Muller” Hospital, Mulhouse, France e-mail: LEBOUARR@ghrmsa.fr;
didier.bresson@ghrmsa.fr; bree.lawson@ghrmsa.fr; marine.kinnel@ghrmsa.fr; laurent.dietrich@ghrmsa.fr; kenizoud@ghrmsa.fr; jacqueminl@ghrmsa.fr
F. Halbwachs Biosense Webster, Mulhouse, France
embolism at the age of 38 years with negative thrombophilia tests; NONSTEMI at the age of 42 years with occlusion of the right coronary artery in the third segment; and gastroduodenal ulcer at the age of 35years was admitted to the emergency department for an episode of palpita­tions with sudden onset accompanied by dizzi­ness that had started 25min prior.
His cardiovascular risk factors were repre­sented by a past history of smoking (20 pack­years), arterial hypertension, dyslipidemia, and grade 2 obesity. His medication at home con­sisted of ramipril 10 mg, atorvastatin 40 mg, aspirin 75mg, bisoprolol 5mg, ivabradine 5mg twice daily, and pantoprazole 40mg.
At physical examination, his blood pressure was 112/71 mmHg, HR 145 bpm, SpO2 96% breathing room air, H=1.74m, W=110kg, and BMI=36.33kg/m2, heart sounds were rapid and regular, there were no audible murmurs, lung auscultation was clear, and there were no signs of right heart failure.
His biological workup showed a Hb level of
13.3 g/dL, leukocytes 6.63 × 109/L, platelets 314×109/L, CRP 4mg/L, BUN 5.7mmol/L, cre­atinine 101 μmol/L, glycemia 5.9 mmol/L (non- fasting), Na+143mmol/L, K+ 4.0mmol/L, cTnI 0.07ng/mL, TSH 3.13IU/L, total choles­terol 168mg/dL, HDL 46 mg/dL, LDL 98 mg/ dL, and triglycerides 120mg/dL.
His ECG at presentation is showed in Fig. 18.1. His ECG recorded 30 s later is pre­sented in Fig.18.2. He presented several episodes
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023 L. Muresan (ed.), Clinical Cases in Cardiac Electrophysiology: Ventricular Arrhythmias,
https://doi.org/10.1007/978-3-031-35579-0_18
279
280
https://t.me/medicina_free
Fig. 18.1 A 12-lead ECG recorded at admission showing a wide QRS complex tachycardia with a heart rate of 145bpm, with a LBBB aspect, and superior axis
R. Le Bouar et al.
Fig. 18.2 A 12-lead ECG showing the spontaneous ter­mination of the wide QRS complex tachycardia with con­version to sinus rhythm with a heart rate of 76bpm; QRS axis at 60°; Q waves in leads II, III, and aVF suggestive of
of the same wide QRS complex tachycardia that were incessant.
Transthoracic echocardiography was per-
formed during one of such episodes, which dem-
remote inferior myocardial infarction; negative T waves in leads II, III, and aVF, and attened in V5 and V6, sugges­tive of possible infero-lateral ischemia
onstrated a non-dilated LV, but with akinesia of the inferior LV wall and with moderate systolic dysfunction, absence of pericardial effusion, and a non-dilated IVC (Fig.18.3).
18 Case 18
https://t.me/medicina_free
281
Fig. 18.3 Left panel: M mode echocardiography show­ing a non-dilated left ventricle, with an end-diastolic diameter of 51 mm. Right panel: Apical four-chamber
Fig. 18.4 Left panel: M mode echocardiography show­ing a non-dilated left ventricle, with an end-diastolic diameter of 56 mm. Right panel: Apical four-chamber
Intravenous amiodarone was administered at a dose of 300mg, with cessation of the tachycar­dia. Transthoracic echocardiography was repeated during sinus rhythm, which showed a non-dilated LV with moderate systolic dysfunc­tion (LVEF of 44%), non-elevated LV lling pressure, mild septal LV hypertrophy, absence of mitral regurgitation, a non-dilated right ventricle, mild tricuspid regurgitation with sPAP of 27 mmHg, absence of pericardial uid, and absence of LV thrombus (Fig.18.4).
The patient’s chest X-ray is presented in Fig.18.5.
view showing a non-dilated LV with severe systolic dys­function, with a LVEF% of 33% (single-plane Simpson method)
view showing pulsed Doppler interrogation of the trans­mitral ux, showing a pseudo-normal LV diastolic dysfunction
Question 1: What is the nature of the
tachycardia presented in Fig. 18.1?
A. SVT with functional RBBB B. Antidromic tachycardia C. Ventricular tachycardia D. Atrial utter with 1:1 AV conduction E. Atrial brillation with BBB
Figure 18.1 explained (see below): This shows a wide QRS complex tachycardia with a heart rate of 145bpm, with a LBBB aspect, and
282
https://t.me/medicina_free
Fig. 18.5 Chest radiography image in posteroanterior view showing a normal cardiothoracic index, absence of pleural effusion, and absence of an obvious infections which trigger at the level of the pulmonary parenchyma
R. Le Bouar et al.
superior axis. Capture beats (*) and fusion beats can be observed (**), favoring the diagnosis of ventricular tachycardia. Of note, the aspect of the QRS complex is not that of a typical LBBB, with transition of the QRS complex in precordial leads in V2, another argument in favor of VT.A-V dis­sociation is also observed, with blue arrows pointing to P waves.
18 Case 18
https://t.me/medicina_free
283
Fig. 18.6 Left upper panel: angiography image of the left coronary artery in LAO view showing no major obstruction of the LAD and CX epicardial vessels. Right upper panel: angiography image of the left coronary artery in posteroanterior view showing no major obstruc­tion of the left main, LAD and CX coronary arteries. Left
In order to rule out ongoing myocardial isch­emia, given the diagnostic of ventricular tachy­cardia and the slightly elevated troponin level, coronary angiography was performed, which demonstrated chronic total occlusion of the RCA in its distal segment (Fig.18.6), an aspect already described during the last coronary angiography performed 1year prior. Of note, no PTCA was
lower panel: chronic total occlusion of the epicardial right coronary artery in its third segment (red arrow). Right lower panel: retrograde lling of the distal part of the right coronary artery from the left coronary artery (red arrow), in favor of a chronic occlusion of the right coro­nary artery
performed at that time, given the lack of myocar­dial viability at the level of the inferior LV wall demonstrated by the stress echocardiography performed prior to the coronary angiography.
A cardiac MRI was subsequently performed, which conrmed the lack of myocardial viability at the level of the LV inferior wall and the absence of inducible ischemia in the other territories and
284
https://t.me/medicina_free
Fig. 18.7 Left panel: cardiac MRI image in cine SSFP three-chamber view showing a non-dilated left ventricle. Right panel: cardiac MRI image in cine SSFP short-axis view showing a non-dilated left and right ventricle
R. Le Bouar et al.
which conrmed the moderate LV systolic dys­function (Fig.18.7).
Given the diagnosis of ventricular tachycar­dia, the presence of remote inferior myocardial infarction, the young age of the patient and the high rate of adverse effects associated with long- term amiodarone administration, and the superiority of catheter ablation to anti-arrhyth­mic drugs in the treatment of VT, an electro­physiological study in view of a catheter ablation procedure was scheduled and subse­quently performed.
Question 2: Where is the origin of the
ventricular tachycardia?
A. Septal right ventricle B. Infero-septal left ventricle C. LV apex D. Infero-lateral left ventricle E. Infero-septal right ventricle
Electrophysiological Study andRF Catheter Ablation Procedure
The electrophysiological study was performed under local anesthesia and conscious sedation. Vascular access was obtained using the modied Seldinger technique, under Doppler ultrasound guidance. A 6F bipolar non-steerable catheter (Viking, Boston Scientic®) was introduced in a 6F 20cm vascular sheath and was subsequently advanced via the right common femoral vein up to the right ventricular apex.
The CARTO ® 3 electro-anatomic mapping system (Biosense Webster, Johnson & Johnson) was used to guide mapping and ablation.
Ventricular pacing was carried out at twice the diastolic threshold using the EP-4™ Cardiac Stimulator (Abbott®) system. Surface ECG and intracavitary ECGs were recorded by the WorkMate Claris™ System (Abbott®). The ECG at the beginning of the ablation procedure is pre­sented in Fig.18.8.
18 Case 18
https://t.me/medicina_free
Fig. 18.8 A 12-lead ECG recorded at the beginning of the ablation procedure showing sinus rhythm with a heart rate of 63bpm, QRS axis at +60°, absence of LV hypertrophy, and inferior wall necrosis
285
Programmed ventricular pacing was per­formed under basal conditions with repeated induction of a wide QRS complex tachycardia with a cycle length of 320ms (Fig.18.9), with a morphology different from that of the clini­cal VT.
Question 3: Given the fact that this ven-
tricular tachycardia is different from the patient’s clinical VT, should this VT be treated with catheter ablation?
A. No. This is not the patient’s clinical
VT; therefore, no indication for catheter ablation exists.
B. No. This is probably related to the
stimulation protocol and should not be ablated.
C. Yes. This should also be ablated,
since the goal of a catheter ablation procedure for VT is ablation of all monomorphic sustained VTs.
D. Yes. This should be ablated during a
second catheter ablation procedure.
E. I don’t know.
A Biosense Webster® SmartTouch SF open­irrigated 3.5mm tip with double curve D/F was placed in the right atrium via a 6F 20cm vascular sheath inserted at the level of the right common femoral vein. It conrmed A-V dissociation dur­ing the tachycardia and the diagnosis of VT.The tachycardia was stopped by burst ventricular pacing.
Given the monomorphic aspect of the VT and its repeated induction during programmed ven­tricular stimulation, ablation of this VT was decided.
Question 4: Where is the origin of the
ventricular tachycardia presented in Fig. 18.5?
A. LV lateral wall B. LV anterior wall C. LV inferior wall D. LV septum E. LV apex
Its RBBB aspect and its relatively narrow QRS complex were in favor of a septal origin in